Drug therapy for detrusor hyperactivity: Where are we?
- 1 January 1985
- journal article
- research article
- Published by Wiley in Neurourology and Urodynamics
- Vol. 4 (4) , 337-351
- https://doi.org/10.1002/nau.1930040411
Abstract
Drug therapy for detrusor hyperactivity can be directed either at decreasing bladder contractility or decreasing sensory input during filling. The agents available to accomplish these purposes are reviewed. Certain questions are raised regarding studies assessing the action of pharrnacologic agents on lower urinary tract storage failure.Keywords
This publication has 72 references indexed in Scilit:
- Calcium physiology in smooth muscleProgress in Cardiovascular Diseases, 1982
- The Lack of Effect of Intramuscular Emepronium Bromide for Urinary IncontinenceBritish Journal of Urology, 1982
- Cardiotoxicity of antidepressant drugsNeuropharmacology, 1980
- Functional evidence for subsensitivity of noradrenergic α2 receptors after chronic desipramine treatmentLife Sciences, 1980
- Imipramine Cardiotoxicity: An Electrocardiographic and Haemodynamic Study in RabbitsActa Pharmacologica et Toxicologica, 1980
- Tricyclic AntidepressantsNew England Journal of Medicine, 1978
- Effect of Ritodrine on the Bladder Capacity in Unanaesthetized PigsActa Pharmacologica et Toxicologica, 1978
- Effects of Calcium and Calcium Antagonists on the Excitation‐Contraction Coupling in Striated and Smooth MuscleActa Pharmacologica et Toxicologica, 1978
- Cardiac Antiarrhythmic Effect of Imipramine HydrochlorideNew England Journal of Medicine, 1977
- Treatment of Detrusor Hyperreflexia in Multiple SclerosisUrologia Internationalis, 1977